0001896665-21-000001.txt : 20211202
0001896665-21-000001.hdr.sgml : 20211202
20211202115406
ACCESSION NUMBER: 0001896665-21-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
ITEM INFORMATION: Investment Company Act Section 3(c)
ITEM INFORMATION: Section 3(c)(1)
ITEM INFORMATION: Section 3(c)(7)
FILED AS OF DATE: 20211202
DATE AS OF CHANGE: 20211202
EFFECTIVENESS DATE: 20211202
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Health Catalyst Capital Annex Fund I, L.P.
CENTRAL INDEX KEY: 0001894170
IRS NUMBER: 873103741
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-423304
FILM NUMBER: 211465510
BUSINESS ADDRESS:
STREET 1: 515 MADISON AVENUE
STREET 2: SUITE 2701
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-752-2226
MAIL ADDRESS:
STREET 1: 515 MADISON AVENUE
STREET 2: SUITE 2701
CITY: NEW YORK
STATE: NY
ZIP: 10022
D
1
primary_doc.xml
X0708
D
LIVE
0001894170
Health Catalyst Capital Annex Fund I, L.P.
515 MADISON AVENUE
SUITE 2701
NEW YORK
NY
NEW YORK
10022
212-752-2226
DELAWARE
None
None
Limited Partnership
true
2021
N/A
Health Catalyst Associates Annex, LLC
515 Madison Avenue
Suite 2701
New York
NY
NEW YORK
10022
Director
General Partner of the Issuer.
Charles
Boorady
515 Madison Avenue
Suite 2701
New York
NY
NEW YORK
10022
Executive Officer
Daniel
Ross
515 Madison Avenue
Suite 2701
New York
NY
NEW YORK
10022
Executive Officer
Pooled Investment Fund
Venture Capital Fund
false
Decline to Disclose
- 06b
- 3C
- 3C.1
- 3C.7
false
2021-11-26
false
true
false
9723
10000000
10000000
0
Total Offering Amount and Total Amount Sold are inclusive of the General Partner's commitment.
false
7
0
0
0
false
Health Catalyst Capital Annex Fund I, L.P.
/s/ Charles Boorady
Charles Boorady
Manager of the General Partner
2021-12-02